Stefan Luzi - Gilde Healthcare

team
Venture&Growth

All team members
Stefan Luzi
Partner Therapeutics
Venture&Growth
The Netherlands

Stefan Luzi

Partner - Therapeutics
Venture&Growth

Stefan Luzi joined Gilde Healthcare in 2015. He is focusing on venture and growth capital investments in the biopharmaceutical sector. He led several investments and currently represents Gilde on the boards of Lava Therapeutics B.V. and Amphista Therapeutics Ltd.

Prior to joining Gilde, Stefan worked at Merck KGaA where he completed international assignments in the Global Business Intelligence and M Ventures divisions. Additionally, he was involved in various consulting projects spanning the pharmaceutical and chemical departments at Merck and co-moderated Merck Serono’s innovation competitions.

Stefan received a B.Sc. in Biology and M.Sc. in Biotechnology from the Swiss Federal Institute of Technology Zurich (ETH) and his MPhil in Bioscience Enterprise from the University of Cambridge. He completed his Ph.D. with Nobel Laureate Sir Gregory Winter at the MRC Laboratory of Molecular Biology in Cambridge, where he developed a bicyclic peptide-based drug discovery platform.

He is a Swiss citizen based in Gilde’s Utrecht office.

Arthur Franken

General Partner Healthtech/Therapeutics
Venture&Growth
Arthur Franken joined Gilde in 2001 and was part of the founding team of Gilde Healthcare. He is focusing on venture and growth capital investments in the biopharm, medtech, diagnostics and digital health sectors. He...

Edward Hanlon

Associate Healthtech
Venture&Growth
Edward Hanlon joined Gilde Healthcare in 2020 in the Cambridge office and focuses on Healthtech. Prior to joining Gilde, Edward worked in advisory for Health Advances, a consulting firm operating across healthcare sectors in medical...

Mika Nishimura

Operational Partner
Mika Nishimura is a seasoned senior executive with over 20 years of leadership experience in medical device industry. During her tenure as the Director of Global Marketing at Guidant Vascular Intervention and Vice President, International...